Garware Fulflex Acquires 300,000-Sq.-Ft. U.S. Medical Manufacturing Facility

Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas, marking a major milestone in the company’s global healthcare growth strategy and significantly expanding its manufacturing footprint in North America.

Situated on a 30-acre campus, the Jacksonville facility employs more than 250 people and manufactures a broad range of critical medical products used by healthcare providers and patients across North America and around the world. The highly automated facility features advanced injection molding, blow molding, thermoforming, extrusion, assembly, and quality systems, further strengthening Garware Fulflex’s ability to serve leading global healthcare companies with world-class manufacturing capabilities.

The acquisition significantly enhances the company’s manufacturing presence in the United States and reinforces its long-term strategy of building a leading global healthcare manufacturing platform.

“This acquisition represents a defining milestone in our journey to build a globally respected healthcare manufacturing company,” said Diya Garware Ibanez, Chairperson of Garware Fulflex. “The Jacksonville facility brings exceptional people, world-class manufacturing capabilities, and an important presence in the world’s largest healthcare market. Most importantly, we are proud to welcome more than 250 talented employees to the Fulflex family. Together, we will continue delivering high-quality medical products while investing in innovation, operational excellence, and long-term growth.”

With the addition of Jacksonville, Garware Fulflex continues to strengthen its global manufacturing network, providing customers with increased production capacity, enhanced technical expertise, supply chain resilience, and greater proximity to the North American healthcare market.


Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.